| Product Name | MF | CAS | Details |
|---|
| (7S)-7-phenyl-4-thia-1,6-diazabicyclo[3.3.0]oct-5-ene hydrochloride | C11H13ClN2S | 74191-78-9 | Details |
| MOPS | C7H15NO4S | 1132-61-2 | Details |
| Albendazole | C12H15N3O2S | 54965-21-8 | Details |
| Oxyclozanide | C13H6Cl5NO3 | 2277-92-1 | Details |
| 3,5-Diiodosalicylic acid potassium salt | C7H5I2NaO3 | 17274-17-8 | Details |
| Isovanillin | C8H8O3 | 621-59-0 | Details |
| Oxibendazole | C12H15N3O3 | 20559-55-1 | Details |
| Triclabendazole | C14H9Cl3N2OS | 68786-66-3 | Details |
| 1,3-Propanesultone | C3H6O3S | 1120-71-4 | Details |
| Thiabendazole | C10H7N3S | 148-79-8 | Details |
| Luxabendazole | C15H12FN3O5S | 90509-02-7 | Details |
| 2-(1,3-thiazol-4-yl)-1H-benzoimidazole | C10H7N3S | 98002-42-7 | Details |
| Benzimidazole | C7H6N2 | 51-17-2 | Details |
| 3,5-Diiodosalicylic acid | C7H4I2O3 | 133-91-5 | Details |
| Febantel | C20H22N4O6S | 58306-30-2 | Details |
| Flubendazole | C16H12FN3O3 | 31430-15-6 | Details |
| 4-Morpholineethanesulfonic acid | C6H13NO4S | 4432-31-9 | Details |
| Albendazole S-oxide | C12H15N3O3S | 54029-12-8 | Details |
| Levamisole | C11H12N2S | 14769-73-4 | Details |
| Oxfendazole | C15H13N3O3S | 53716-50-0 | Details |
| Rafoxanide | C19H11Cl2I2NO3 | 22662-39-1 | Details |
| PIPES | C8H18N2O6S2 | 5625-37-6 | Details |
| Closantel sodium | C22H15Cl2I2N2NaO2 | 61438-64-0 | Details |
| Parbendazole | C13H17N3O2 | 14255-87-9 | Details |
| Closantel | C22H14Cl2I2N2O2 | 57808-65-8 | Details |
| HEPES | C8H18N2O4S | 7365-45-9 | Details |
| Carbendazim | C9H9N3O2 | 10605-21-7 | Details |
| Niclosamide | C13H8Cl2N2O4 | 50-65-7 | Details |
| Levamisole hydrochloride | C11H13ClN2S | 16595-80-5 | Details |
| Tris(hydroxymethyl)aminomethane | C4H11NO3 | 77-86-1 | Details |
| Mebendazole | C16H13N3O3 | 31431-39-7 | Details |
| 2-(1,3-thiazol-4-yl)-1H-benzoimidazole | C10H7N3S | 945-65-3 | Details |
| Fenbendazole | C15H13N3O2S | 43210-67-9 | Details |
| 3,5-DIIODOBENZAMIDE | C7H5I2NO | 4039-18-3 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||